• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唾液组学:当前现状

Salivaomics: The current scenario.

作者信息

Shah Sonalee

机构信息

Department of Oral Pathology and Microbiology, Government Dental College, Raipur, Chhattisgarh, India.

出版信息

J Oral Maxillofac Pathol. 2018 Sep-Dec;22(3):375-381. doi: 10.4103/jomfp.JOMFP_171_18.

DOI:10.4103/jomfp.JOMFP_171_18
PMID:30651683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6306596/
Abstract

For generations, blood has been the medium of choice for diagnosing most diseases and conditions. The reason for this is mainly the limitations of technology. The concept of oral diagnostics is preferred to more invasive methods. In recent years, it has become evident that the salivary constituents become detectably altered in response to certain disease states. Even so, what is most impressive is that salivary biomarkers not only arise in correlation with oral disorders but also those of distal tissues and organs. This suggests that oral fluids may represent a substantial reservoir of molecular and microbial information capable of communicating the onset or presence of disease throughout the body. An initiative of the National Institute of Dental and Craniofacial Research created a roadmap to achieve these goals whereby, with the use of oral fluids as the diagnostic medium, it would become possible to scrutinize the health and/or disease status of patients. The real promise of salivary analysis use is the ability of the patient or clinician to directly and continuously assess disease status, progression and therapeutic efficacy. The sensitive analysis may even allow presymptomatic diagnosis. There are five major diagnostic alphabets available in saliva namely, proteins, messenger RNAs, micro-RNAs (mi-RNAs), metabolic compounds and microbes which offer substantial advantages for salivary diagnostics because, the state of the disease may be associated with detectable changes in one, but not all, dimensions. Recently, the Salivaomics Knowledge Base (SKB) has been established by aligning the salivary biomarker discovery. The SKB constitutes data repository, management system and web resource fabricated to support human salivary proteomics, transcriptomics, miRNA, metabolomics and microbiome research.

摘要

几代人以来,血液一直是诊断大多数疾病和病症的首选介质。其原因主要是技术的局限性。相比于侵入性更强的方法,口腔诊断的概念更受青睐。近年来,有一点已变得很明显,即唾液成分会因某些疾病状态而发生可检测到的变化。即便如此,最令人印象深刻的是,唾液生物标志物不仅与口腔疾病相关,还与远端组织和器官的疾病相关。这表明口腔液体可能代表了一个大量的分子和微生物信息库,能够传达全身疾病的发生或存在情况。美国国立牙科和颅面研究所发起了一项倡议,制定了实现这些目标的路线图,即通过使用口腔液体作为诊断介质,有可能仔细检查患者的健康和/或疾病状况。唾液分析应用的真正前景在于患者或临床医生能够直接且持续地评估疾病状态、进展和治疗效果。灵敏的分析甚至可能实现症状前诊断。唾液中有五种主要的诊断“字母”,即蛋白质、信使核糖核酸、微小核糖核酸(miRNA)、代谢化合物和微生物,它们为唾液诊断提供了显著优势,因为疾病状态可能与某一个而非所有维度上可检测到的变化相关。最近,通过整合唾液生物标志物发现建立了唾液组学知识库(SKB)。SKB由数据存储库、管理系统和网络资源构成,旨在支持人类唾液蛋白质组学、转录组学、miRNA、代谢组学和微生物组研究。

相似文献

1
Salivaomics: The current scenario.唾液组学:当前现状
J Oral Maxillofac Pathol. 2018 Sep-Dec;22(3):375-381. doi: 10.4103/jomfp.JOMFP_171_18.
2
Salivaomics - A promising future in early diagnosis of dental diseases.唾液组学——牙科疾病早期诊断的光明未来。
Dent Res J (Isfahan). 2014 Jan;11(1):11-5.
3
Salivary diagnostics powered by nanotechnologies, proteomics and genomics.由纳米技术、蛋白质组学和基因组学驱动的唾液诊断技术。
J Am Dent Assoc. 2006 Mar;137(3):313-21. doi: 10.14219/jada.archive.2006.0180.
4
The New Era of Salivaomics in Dentistry: Frontiers and Facts in the Early Diagnosis and Prevention of Oral Diseases and Cancer.口腔医学中唾液组学的新时代:口腔疾病和癌症早期诊断与预防的前沿与事实
Metabolites. 2022 Jul 12;12(7):638. doi: 10.3390/metabo12070638.
5
Bioinformatics advances in saliva diagnostics.唾液诊断的生物信息学进展。
Int J Oral Sci. 2012 Jun;4(2):85-7. doi: 10.1038/ijos.2012.26.
6
Salivary diagnostics.唾液诊断学。
Orthod Craniofac Res. 2009 Aug;12(3):206-11. doi: 10.1111/j.1601-6343.2009.01454.x.
7
Saliva Ontology: an ontology-based framework for a Salivaomics Knowledge Base.唾液本体论:基于本体的唾液组学知识库框架。
BMC Bioinformatics. 2010 Jun 3;11:302. doi: 10.1186/1471-2105-11-302.
8
Salivary diagnostics: enhancing disease detection and making medicine better.唾液诊断:增强疾病检测能力,优化医疗水平。
Eur J Dent Educ. 2008 Feb;12 Suppl 1(Suppl 1):22-9. doi: 10.1111/j.1600-0579.2007.00477.x.
9
Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment.唾液代谢组学为生物标志物的发现、疾病诊断和治疗开辟了大门。
Appl Biochem Biotechnol. 2012 Nov;168(6):1718-27. doi: 10.1007/s12010-012-9891-5. Epub 2012 Sep 13.
10
Scientific frontiers: emerging technologies for salivary diagnostics.科学前沿:唾液诊断的新兴技术
Adv Dent Res. 2011 Oct;23(4):360-8. doi: 10.1177/0022034511420433.

引用本文的文献

1
Can Salivary Biomarkers Serve as Diagnostic and Prognostic Tools for Early Detection in Patients with Colorectal Cancer? A Systematic Review.唾液生物标志物能否作为结直肠癌患者早期检测的诊断和预后工具?一项系统综述。
Curr Issues Mol Biol. 2025 Aug 12;47(8):647. doi: 10.3390/cimb47080647.
2
Salivaomic Biomarkers-An Innovative Approach to the Diagnosis, Treatment, and Prognosis of Oral Cancer.唾液生物标志物——口腔癌诊断、治疗和预后的创新方法。
Biology (Basel). 2025 Jul 13;14(7):852. doi: 10.3390/biology14070852.
3
The Salivary Transcriptome: A Window into Local and Systemic Gene Expression Patterns.唾液转录组:洞察局部和全身基因表达模式的窗口。
Methods Mol Biol. 2025;2880:1-16. doi: 10.1007/978-1-0716-4276-4_1.
4
Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis.基于代谢组学的乳腺癌预后和诊断生物标志物发现
Cells. 2024 Dec 25;14(1):5. doi: 10.3390/cells14010005.
5
Salivaomics: A Revolutionary Non-invasive Approach for Oral Cancer Detection.唾液组学:一种用于口腔癌检测的革命性非侵入性方法。
Cureus. 2024 Nov 25;16(11):e74381. doi: 10.7759/cureus.74381. eCollection 2024 Nov.
6
Beta-defensin index: A functional biomarker for oral cancer detection.β-防御素指数:口腔癌检测的功能性生物标志物。
Cell Rep Med. 2024 Mar 19;5(3):101447. doi: 10.1016/j.xcrm.2024.101447. Epub 2024 Mar 4.
7
Critical Factors in Sample Collection and Preparation for Clinical Metabolomics of Underexplored Biological Specimens.未充分探索的生物样本临床代谢组学样本采集与制备中的关键因素
Metabolites. 2024 Jan 5;14(1):36. doi: 10.3390/metabo14010036.
8
Leveraging technology-driven strategies to untangle omics big data: circumventing roadblocks in clinical facets of oral cancer.利用技术驱动的策略来理清组学大数据:规避口腔癌临床方面的障碍。
Front Oncol. 2024 Jan 3;13:1183766. doi: 10.3389/fonc.2023.1183766. eCollection 2023.
9
Human Serum and Salivary Metabolomes: Diversity and Closeness.人血清和唾液代谢组学:多样性与相似度。
Int J Mol Sci. 2023 Nov 22;24(23):16603. doi: 10.3390/ijms242316603.
10
A Narrative Review on Strategies for the Reversion of Prediabetes to Normoglycemia: Food Pyramid, Physical Activity, and Self-Monitoring Innovative Glucose Devices.关于将糖尿病前期逆转为正常血糖水平的策略的叙述性综述:食物金字塔、身体活动和自我监测创新型血糖设备。
Nutrients. 2023 Nov 28;15(23):4943. doi: 10.3390/nu15234943.

本文引用的文献

1
Saliva as a diagnostic tool for oral and systemic diseases.唾液作为口腔和全身性疾病的诊断工具。
J Oral Biol Craniofac Res. 2016 Jan-Apr;6(1):66-75. doi: 10.1016/j.jobcr.2015.08.006. Epub 2015 Sep 9.
2
Diagnostic applications of saliva in dentistry.唾液在牙科中的诊断应用。
Int J Clin Pediatr Dent. 2009 Sep;2(3):7-13. doi: 10.5005/jp-journals-10005-1012. Epub 2009 Dec 26.
3
Protein biomarkers of periodontitis in saliva.唾液中牙周炎的蛋白质生物标志物。
ISRN Inflamm. 2014 Apr 22;2014:593151. doi: 10.1155/2014/593151. eCollection 2014.
4
Saliva diagnostics: utilizing oral fluids to determine health status.唾液诊断:利用口腔液体确定健康状况。
Monogr Oral Sci. 2014;24:88-98. doi: 10.1159/000358791. Epub 2014 May 23.
5
Salivary biomarkers: toward future clinical and diagnostic utilities.唾液生物标志物:未来的临床和诊断应用。
Clin Microbiol Rev. 2013 Oct;26(4):781-91. doi: 10.1128/CMR.00021-13.
6
A review on salivary genomics and proteomics biomarkers in oral cancer.口腔癌唾液基因组学和蛋白质组学生物标志物综述。
Indian J Clin Biochem. 2011 Oct;26(4):326-34. doi: 10.1007/s12291-011-0149-8. Epub 2011 Aug 9.
7
Saliva as a diagnostic fluid.唾液作为一种诊断液。
Dent Clin North Am. 2011 Jan;55(1):159-78. doi: 10.1016/j.cden.2010.08.004.
8
Proteomics of saliva: personal experience.唾液蛋白质组学:个人经验。
Acta Otorhinolaryngol Ital. 2010 Jun;30(3):125-30.